Role of PDGFs/PDGFRs signaling pathway in myocardial fibrosis of DOCA/salt hypertensive rats

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 16-27

  Fan, Bin ^a   Ma, Likun ^a   Li, Qian ^a   Wang, Lin ^a   Zhou, Junling ^a   Wu, Jiawei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Desoxycorticosterone; Fibroblasts; Imatinib; Myocardial fibrosis; Myofibroblasts; Platelet derived growth factor; Platelet derived growth factor receptor

Indexed keywords

DEOXYCORTICOSTERONE; IMATINIB; MINERALOCORTICOID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL; ARTICLE; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FIBROBLAST; FIBROSIS; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MYOFIBROBLAST; PATHOLOGY; PHYSIOLOGY; PLATELET-DERIVED GROWTH FACTOR RECEPTOR; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

DESOXYCORTICOSTERONE; FIBROBLASTS; IMATINIB; MYOCARDIAL FIBROSIS; MYOFIBROBLASTS; PLATELET-DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR RECEPTOR;

ANIMALS; CARDIOMYOPATHIES; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MINERALOCORTICOIDS; MYOFIBROBLASTS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84891693607     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S and Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13: 952-961.
2. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
3. Ma LK, Li Q, He LF, Hua JS, Zhou JL, Yu H, Feng KF, Chen HW, Hu H and Wang L. Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRalpha activity. Arq Bras Cardiol 2012; 99: 1082-1091.
4. Yu M, Ishibashi-Ueda H, Ohta-Ogo K, Gabbiani G, Yamagishi M, Hayashi K, Hirota S, Bochaton-Piallat ML and Hao H. Transient expression of cellular retinol-binding protein-1 during cardiac repair after myocardial infarction. Pathol Int 2012; 62: 246-253.
5. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML and Frangogiannis NG. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 2006; 48: 2315-2323.
6. Ishimaru K, Ueno H, Kagitani S, Takabayashi D, Takata M and Inoue H. Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats. J Cardiovasc Pharmacol 2007; 50: 187-194.
7. Leipner C, Grun K, Muller A, Buchdunger E, Borsi L, Kosmehl H, Berndt A, Janik T, Uecker A, Kiehntopf M and Bohmer FD. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Cardiovasc Res 2008; 79: 118-126.
8. Andrae J, Gallini R and Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008; 22: 1276-1312.
9. Donovan J, Abraham D and Norman J. Platelet-derived growth factor signaling in mesenchymal cells. Front Biosci (Landmark Ed) 2013; 18: 106-119.
10. Zhao T, Zhao W, Chen Y, Li VS, Meng W and Sun Y. Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2013; 304: H1719-1726.
11. Porter KE and Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 2009; 123: 255-278.
12. Yue L, Xie J and Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011; 89: 744-753.
13. Camelliti P, Borg TK and Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005; 65: 40-51.
14. Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA and Sun Y. Platelet-derived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol 2011; 51: 830-838.
15. Sun Y and Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 2000; 46: 250-256.
16. Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, Seidman CE and Seidman JG. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta. J Clin Invest 2010; 120: 3520-3529.
17. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004; 15: 237-254.